Novo Integrated Sciences, Inc.

NasdaqCM:NVOS Stock Report

Mkt Cap: US$11.0m

Novo Integrated Sciences Financial Health

How is Novo Integrated Sciences's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: NVOS's short term assets ($20.1M) exceed its short term liabilities ($12.7M).

Long Term Liabilities: NVOS's short term assets ($20.1M) exceed its long term liabilities ($14.6M).


Debt to Equity History and Analysis

Debt Level: NVOS's net debt to equity ratio (14.2%) is considered satisfactory.

Reducing Debt: NVOS had negative shareholder equity 5 years ago, but is now positive and has therefore improved.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NVOS has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NVOS has less than a year of cash runway if free cash flow continues to reduce at historical rates of 35.1% each year


Discover healthy companies